Alejandra Gutierrez Guerrero, PhD is a Product Manager in Cell Therapy at Grifols, where she leads product strategy, market analysis, and cross functional coordination for cell therapy solutions.

She holds a PhD in Biomedicine from the University of Granada, with a research focus on gene editing technologies for gene therapy. She subsequently completed postdoctoral training at Weill Cornell Medical College (New York, USA) and at the École Normale Supérieure (Lyon, France), where she worked on CRISPR based disease models, lentiviral vector optimization, and CAR T cell engineering. Prior to joining Grifols, she led preclinical programs for allogeneic CAR T therapies as an R&D Scientist and Project Manager, managing external partners and regulatory documentation. 

Her profile bridges translational cell and gene therapy expertise with product  and market oriented strategy in the biotherapies field.